HACKENSACK, N.J.--(BUSINESS WIRE)--ReGen Biologics (OTC: RGBO) (“ReGen”) announced today that its Board of Directors approved a 1-for-20 reverse split of ReGen’s common stock. The split became effective at 11:59 p.m., Eastern Standard Time, on November 29, 2008 (the “Effective Time”) and trading under the new ticker begins at the open on December 1, 2008.
